Please wait...

Learn

Finding accredited CPD

The GPs Role in MS: High-Efficacy Therapy Update

Description

Multiple sclerosis (MS) is a chronic disorder with an increasing worldwide incidence, and as a result, GPs play a vital role in managing patients through all stages of their journey. This live webinar builds upon the core learning module, allowing you to apply knowledge to real-world patient scenarios, deepen your understanding of modern disease-modifying treatments (DMTs), and consolidate your role in long-term collaborative care. This is your opportunity to bring your specific questions to our experts in a live Q&A session and gain practical, actionable strategies for optimising care for your patients with MS.

Learning Outcomes

  1. Summarise MS prognosis and treatment goals
  2. Describe diagnostic criteria and referral pathways
  3. Outline the comprehensive approach to MS treatment, including DMTs
  4. Recognise best practice (early HETs) and identify patients for switching
  5. Identify pre- and post-DMT tests for monitoring and risk mitigation.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

 

Provided by

CPD Activity Details
Topic
General Practice and Primary Care, Nervous System Diseases, Patient outcomes
CAPE Aspects
Professionalism
Effective Year

Educational Activities (EA) - 1.30

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s Registration Standard: Continuing professional development (the Standard)